Baxter to build $1B plasma fractionation facility in Georgia

04/19/2012 | Genetic Engineering & Biotechnology News

Baxter International will invest more than $1 billion in the next five years to build a new manufacturing plant in Covington, Ga., designed to accommodate future expansion. The site will include facilities to manufacture products to treat immune disorders.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Briefs: